PROS1 and COVID-19: The findings align with the hypothesis that androgen-driven mechanisms, including ACE2 receptor activity and TMPRSS2 enzyme expression, may exacerbate COVID-19 outcomes in men.3,15 We believe that ACE receptor expression is more prominent in patients with elevated PSA levels relative to their age, which may result in increased mortality in more severe clinical cases.